The global Glycosylated Peptide market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key manufacturers engaged in the Glycosylated Peptide industry include Sandoz International, Pfizer, Roche, Teva Pharmaceuticals Industries, Celltrion, Biocon, Dr.Reddys Laboratories, Medtronic and Cipla, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Glycosylated Peptide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Glycosylated Peptide market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Glycosylated Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sandoz International
Pfizer
Roche
Teva Pharmaceuticals Industries
Celltrion
Biocon
Dr.Reddys Laboratories
Medtronic
Cipla
Bachem Americas
Segment by Type
Monoclonal Antibodies (MABs)
Erythropoietin (EPO)
Others
Segment by Application
Oncology
Blood Disorder
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glycosylated Peptide report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Glycosylated Peptide Market Overview
1.1 Product Overview and Scope of Glycosylated Peptide
1.2 Glycosylated Peptide Segment by Type
1.2.1 Global Glycosylated Peptide Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Erythropoietin (EPO)
1.2.4 Others
1.3 Glycosylated Peptide Segment by Application
1.3.1 Global Glycosylated Peptide Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Blood Disorder
1.3.4 Others
1.4 Global Glycosylated Peptide Market Size Estimates and Forecasts
1.4.1 Global Glycosylated Peptide Revenue 2018-2029
1.4.2 Global Glycosylated Peptide Sales 2018-2029
1.4.3 Global Glycosylated Peptide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glycosylated Peptide Market Competition by Manufacturers
2.1 Global Glycosylated Peptide Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glycosylated Peptide Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glycosylated Peptide Average Price by Manufacturers (2018-2023)
2.4 Global Glycosylated Peptide Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glycosylated Peptide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycosylated Peptide, Product Type & Application
2.7 Glycosylated Peptide Market Competitive Situation and Trends
2.7.1 Glycosylated Peptide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycosylated Peptide Players Market Share by Revenue
2.7.3 Global Glycosylated Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycosylated Peptide Retrospective Market Scenario by Region
3.1 Global Glycosylated Peptide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glycosylated Peptide Global Glycosylated Peptide Sales by Region: 2018-2029
3.2.1 Global Glycosylated Peptide Sales by Region: 2018-2023
3.2.2 Global Glycosylated Peptide Sales by Region: 2024-2029
3.3 Global Glycosylated Peptide Global Glycosylated Peptide Revenue by Region: 2018-2029
3.3.1 Global Glycosylated Peptide Revenue by Region: 2018-2023
3.3.2 Global Glycosylated Peptide Revenue by Region: 2024-2029
3.4 North America Glycosylated Peptide Market Facts & Figures by Country
3.4.1 North America Glycosylated Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glycosylated Peptide Sales by Country (2018-2029)
3.4.3 North America Glycosylated Peptide Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycosylated Peptide Market Facts & Figures by Country
3.5.1 Europe Glycosylated Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glycosylated Peptide Sales by Country (2018-2029)
3.5.3 Europe Glycosylated Peptide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycosylated Peptide Market Facts & Figures by Country
3.6.1 Asia Pacific Glycosylated Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glycosylated Peptide Sales by Country (2018-2029)
3.6.3 Asia Pacific Glycosylated Peptide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycosylated Peptide Market Facts & Figures by Country
3.7.1 Latin America Glycosylated Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glycosylated Peptide Sales by Country (2018-2029)
3.7.3 Latin America Glycosylated Peptide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycosylated Peptide Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycosylated Peptide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glycosylated Peptide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glycosylated Peptide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glycosylated Peptide Sales by Type (2018-2029)
4.1.1 Global Glycosylated Peptide Sales by Type (2018-2023)
4.1.2 Global Glycosylated Peptide Sales by Type (2024-2029)
4.1.3 Global Glycosylated Peptide Sales Market Share by Type (2018-2029)
4.2 Global Glycosylated Peptide Revenue by Type (2018-2029)
4.2.1 Global Glycosylated Peptide Revenue by Type (2018-2023)
4.2.2 Global Glycosylated Peptide Revenue by Type (2024-2029)
4.2.3 Global Glycosylated Peptide Revenue Market Share by Type (2018-2029)
4.3 Global Glycosylated Peptide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glycosylated Peptide Sales by Application (2018-2029)
5.1.1 Global Glycosylated Peptide Sales by Application (2018-2023)
5.1.2 Global Glycosylated Peptide Sales by Application (2024-2029)
5.1.3 Global Glycosylated Peptide Sales Market Share by Application (2018-2029)
5.2 Global Glycosylated Peptide Revenue by Application (2018-2029)
5.2.1 Global Glycosylated Peptide Revenue by Application (2018-2023)
5.2.2 Global Glycosylated Peptide Revenue by Application (2024-2029)
5.2.3 Global Glycosylated Peptide Revenue Market Share by Application (2018-2029)
5.3 Global Glycosylated Peptide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sandoz International
6.1.1 Sandoz International Corporation Information
6.1.2 Sandoz International Description and Business Overview
6.1.3 Sandoz International Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sandoz International Glycosylated Peptide Product Portfolio
6.1.5 Sandoz International Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Glycosylated Peptide Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Glycosylated Peptide Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Teva Pharmaceuticals Industries
6.4.1 Teva Pharmaceuticals Industries Corporation Information
6.4.2 Teva Pharmaceuticals Industries Description and Business Overview
6.4.3 Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceuticals Industries Glycosylated Peptide Product Portfolio
6.4.5 Teva Pharmaceuticals Industries Recent Developments/Updates
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Description and Business Overview
6.5.3 Celltrion Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Celltrion Glycosylated Peptide Product Portfolio
6.5.5 Celltrion Recent Developments/Updates
6.6 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biocon Glycosylated Peptide Product Portfolio
6.6.5 Biocon Recent Developments/Updates
6.7 Dr.Reddys Laboratories
6.6.1 Dr.Reddys Laboratories Corporation Information
6.6.2 Dr.Reddys Laboratories Description and Business Overview
6.6.3 Dr.Reddys Laboratories Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr.Reddys Laboratories Glycosylated Peptide Product Portfolio
6.7.5 Dr.Reddys Laboratories Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Corporation Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medtronic Glycosylated Peptide Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Glycosylated Peptide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Bachem Americas
6.10.1 Bachem Americas Corporation Information
6.10.2 Bachem Americas Description and Business Overview
6.10.3 Bachem Americas Glycosylated Peptide Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bachem Americas Glycosylated Peptide Product Portfolio
6.10.5 Bachem Americas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycosylated Peptide Industry Chain Analysis
7.2 Glycosylated Peptide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycosylated Peptide Production Mode & Process
7.4 Glycosylated Peptide Sales and Marketing
7.4.1 Glycosylated Peptide Sales Channels
7.4.2 Glycosylated Peptide Distributors
7.5 Glycosylated Peptide Customers
8 Glycosylated Peptide Market Dynamics
8.1 Glycosylated Peptide Industry Trends
8.2 Glycosylated Peptide Market Drivers
8.3 Glycosylated Peptide Market Challenges
8.4 Glycosylated Peptide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Sandoz International
Pfizer
Roche
Teva Pharmaceuticals Industries
Celltrion
Biocon
Dr.Reddys Laboratories
Medtronic
Cipla
Bachem Americas
*If Applicable.